We then confirmed the target specificity of DYB‐03 in vivo and showed that tumor growth was slowed by double knockdown of HIF‐1α and EZH2 in A549, similar to the inhibitory effect of DYB‐03 on parental cells. Here, EZH2 is linked to neoplasm.